Slow to Report

Sponsors aren't reporting clinical trial data like they are supposed to, according to an analysis performed by Duke University researchers.

Part of the Food and Drug Administration Amendments Act requires sponsors to register their non-phase I clinical trials of drugs, medical devices, or biologics, and report basic summary results at within a year of the completion of data collection.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.